Skip to main content

Table 1 Patients and tumor characteristics

From: Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma

Variable No. of patients
Patients demographics
 Gender (male/female) 458 (84.5 %)/84 (15.5 %)
 ECOG (0/1/2) 312 (57.6 %)/170 (31.4 %)/60 (11 %)
 Age (year) (≤60 vs. >60 years) 361 (66.6 %)/181 (33.4 %)
 Hepatitis B (+/−) 421 (77.7 %)/118 (22.3 %)
 Hepatitis C (+/−) 39 (7.2 %)/503 (92.8 %)
 AFP level (≤400 vs. >400 ng/mL) 414 (76.4 %)/128 (23.6 %)
 ALT level (≤40 vs. >40 U/L) 350 (64.6 %)/192 (35.4 %)
 AST level (≤40 vs. >40 U/L) 331 (61.1 %)/211 (38.9 %)
 TBIL level (≤17.5 vs. >17.5 μmol/L) 356 (65.7 %)/186 (34.3 %)
 ALB level (≤35 vs. >35 g/L) 22 (4.1 %)/520 (95.9 %)
 PT (≤14 vs. >14 s) 525 (96.9 %)/17 (3.1 %)
 Liver cirrhosis (+) 390 (72.0 %)/150 (28.0 %)
Tumor characteristics
 Tumor size (≤5 vs. >5) 325 (60.0 %)/217 (40.0 %)
 No. of tumor (single vs. multiple) 473 (87.3 %)/69 (12.7 %)
 Microscopic portal vein thrombosis (+/−) 143 (26.4 %)/399 (73.6 %)
 Macroscopic vascular invasion (+/−) 54 (10.0 %)/488
Surgery details
 Operation time (min) 148 ± 55.6
 Blood lose (≤1000 vs. >1000 mL) 506 (93.4 %)/36 (6.6 %)
 Blood transfusion (n) 60 (11.1 %)
Type of liver resection (minor vs. major) 398 (73.4 %)/144 (26.6 %)
Complications
 Minor (Clavien grade <3) 86 (15.9 %)
 Major (Clavien grade ≥3) 23 (4.2 %)
Hospital stay (day) 13.8 ± 11.6
Child-Pugh grade (A/B) 538 (99.3 %)/4 (0.7 %)
BCLC stage (0/A/B/C) 76 (14.0 %)/208 (38.4 %)/204 (37.6 %)/54 (10 %)